Skip to main content

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Avaluació de teràpies experimentals contra el càncer d'endometri en models animals ortotòpics

IP: Silvia Cabrera Diaz
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 3000
Reference: MMCB/02/2008
Duration: 01/01/2009 - 31/12/2009

Oncologia Translacional

IP: Jaume Reventós Puigjaner
Collaborators: Soledad Gallego Melcón, Manuel López Cano, José Placer Santos, Josep Sánchez de Toledo Codina, Joan Morote Robles, Ma Teresa Quiles Pérez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Miguel Segura Ginard, Manuel Armengol Carrasco, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 57200
Reference: 2009 SGR 487
Duration: 01/01/2010 - 30/04/2014

La gestación como situación de estrés para el desarrollo de enfermedad cardiovascular: Evaluación de marcadores de riesgo hemodinámicos y bioquímicos para la enfemedad arterioesclerótica en madres y fetos con preclampsia y/o retraso de crecimiento.

IP: Elisa Llurba Olivé
Collaborators: Ferran Rosés i Noguer, Maria Queralt Ferrer Menduiña, Inés Zulema Calero Fernández, Silvia Cabrera Diaz, Josep Perapoch López
Funding agency: Instituto de Salud Carlos III
Funding: 61226
Reference: PI07/1095
Duration: 01/01/2008 - 30/06/2011

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Ma Teresa Quiles Pérez, Francina Munell Casadesus, Eva Colas Ortega, Enric Trilla Herrera, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Tomàs Pinós Figueras, Carles Xavier Raventós Busquets, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 350549.54
Reference: RD06/0020/0058
Duration: 02/01/2007 - 31/12/2013

Related news

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

Related professionals

Novica Nikolic

Novica Nikolic

Research assistant
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
María Viñas I Casas

María Viñas I Casas

Predoctoral researcher
Protein kinases in cancer research
Read more
Gino Freddy Sena Ganse

Gino Freddy Sena Ganse

Predoctoral researcher
Cardiovascular Diseases
Read more
Alejandra de la Cruz Trillo

Alejandra de la Cruz Trillo

Research technician
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.